ONCIN Share Price Performance
NOK 46.72
-72.28 (-60.74%)
Price NOK 46.72
Share Pricen/a
Oncoinvent ASA Stock Price
- 0 Narratives written by author
- 0 Comments on narratives written by author
- 1 Fair Values set on narratives written by author
ONCIN Community Narratives
There are no narratives available yet.
There are no community narratives available.
Trending Discussion
Recently Updated Narratives
No recently updated narratives available.
Snowflake Analysis
Oncoinvent ASA Key Details
Last Reported Earnings
Jun 30, 2025
Next Reporting Earnings
Apr 22, 2026
- -23.83
- 100.00%
- -533.74%
- 0%
About ONCIN
- Founded
- n/a
- Employees
- 36
- CEO
- WebsiteView website
Oncoinvent ASA, a clinical stage company, develops radiopharmaceutical therapies against cancer. Its lead product candidate is Radspherin, an alpha-radiation therapy candidate for treating cancer that have spread to body cavities, including peritoneum in two phase 1/2a trials and one randomized phase 2 trial. The company is based in Oslo, Norway.
